In a pan-cancer study of somatic TERT promoter mutations and amplification, Sounak et al. found that among 30,733 specimens, almost 11.3% of cases with TERT promoter mutation were accompanied by 2.3% TERT amplification and 86.3% with no TERT amplification or promoter mutation [40]. This evidence concerns the gene TERT and cancer.